# Effects of Antiemetic Agents in Orthognathic Surgery Patients

> **NCT06454825** · PHASE4 · COMPLETED · sponsor: **Bezmialem Vakif University** · enrollment: 66 (actual)

## Conditions studied

- Emesis, Postoperative
- Maxillofacial Abnormalities

## Interventions

- **DRUG:** Intravenous drug

## Key facts

- **NCT ID:** NCT06454825
- **Lead sponsor:** Bezmialem Vakif University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-14
- **Primary completion:** 2021-04-05
- **Final completion:** 2021-04-05
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2024-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06454825

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06454825, "Effects of Antiemetic Agents in Orthognathic Surgery Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06454825. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*